Molecular Imaging of Vulnerable Plaque by Cardiac Magnetic Resonance Imaging

ABSTRACT

Coronary atherosclerosis is known to be the major cause for morbidity and mortality in the industrial world. In Europe, every year ~600,000 persons die from coronary artery disease, a majority of them without any prior symptoms. Plaque rupture, mostly of noncalcified vulnerable plaques, is supposed to play a major role in this setting, and noninvasive techniques are mandatory to stratify the individual risk for experiencing an acute coronary event. During the last decade, magnetic resonance imaging has gained importance as a noninvasive imaging technique in cardiology. Continuous technical improvements enabled a rapidly expanding field of application, and recently noninvasive imaging of plaques has been introduced. In addition to morphological characterization, functional imaging of plaques has gained interest for a more specific risk assessment. This article summarizes pathophysiological aspects of the concept of vulnerable plaque, technical requirements for noninvasive plaque imaging, and characterization with magnetic resonance imaging.

KEYWORDS

Plaque imaging - molecular imaging - magnetic resonance imaging - contrast agents - coronary artery disease

REFERENCES

• 1 Smith Jr S C, Jackson R, Pearson T A et al.. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum.  Circulation. 2004;  109 3112-3121
• 2 Naghavi M, Libby P, Falk E et al.. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II.  Circulation. 2003;  108 1772-1778
• 3 Naghavi M, Libby P, Falk E et al.. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.  Circulation. 2003;  108 1664-1672
• 4 Nikolaou K, Becker C R, Muders M et al.. Multidetector-row computed tomography and magnetic resonance imaging of atherosclerotic lesions in human ex vivo coronary arteries.  Atherosclerosis. 2004;  174 243-252
• 5 Botnar R M, Stuber M, Kissinger K V, Kim W Y, Spuentrup E, Manning W J. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging.  Circulation. 2000;  102 2582-2587
• 6 Achenbach S, Moselewski F, Ropers D et al.. Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound.  Circulation. 2004;  109 14-17
• 7 Kopp A F, Schroeder S, Baumbach A et al.. Non-invasive characterisation of coronary lesion morphology and composition by multislice CT: first results in comparison with intracoronary ultrasound.  Eur Radiol. 2001;  11 1607-1611
• 8 Leber A W, Knez A, Becker A et al.. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound.  J Am Coll Cardiol. 2004;  43 1241-1247
• 9 Schroeder S, Kopp A F, Baumbach A et al.. Non-invasive characterisation of coronary lesion morphology by multi-slice computed tomography: a promising new technology for risk stratification of patients with coronary artery disease.  Heart. 2001;  85 576-578
• 10 Schroeder S, Kopp A F, Baumbach A et al.. Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography.  J Am Coll Cardiol. 2001;  37 1430-1435
• 11 Jahnke C, Paetsch I, Nehrke K et al.. Rapid and complete coronary arterial tree visualization with magnetic resonance imaging: feasibility and diagnostic performance.  Eur Heart J. 2005;  26 2313-2319
• 12 Ehman R L, Felmlee J P. Adaptive technique for high-definition MR imaging of moving structures.  Radiology. 1989;  173 255-263
• 13 Botnar R M, Stuber M, Lamerichs R et al.. Initial experiences with in vivo right coronary artery human MR vessel wall imaging at 3 tesla.  J Cardiovasc Magn Reson. 2003;  5 589-594
• 14 Hadley J R, Roberts J A, Goodrich K C, Buswell H R, Parker D L. Relative RF coil performance in carotid imaging.  Magn Reson Imaging. 2005;  23 629-639
• 15 Buehrer M, Huber M E, Wiesinger F, Boesiger P, Kozerke S. Coil setup optimization for 2D-SENSE whole-heart coronary imaging.  Magn Reson Med. 2006;  55 460-464
• 16 Blaimer M, Breuer F, Mueller M, Heidemann R M, Griswold M A, Jakob P M. SMASH, SENSE, PILS, GRAPPA: how to choose the optimal method.  Top Magn Reson Imaging. 2004;  15 223-236
• 17 Etienne A, Botnar R M, Van Muiswinkel A M, Boesiger P, Manning W J, Stuber M. “Soap-bubble” visualization and quantitative analysis of 3D coronary magnetic resonance angiograms.  Magn Reson Med. 2002;  48 658-666
• 18 Lorenz C H, Johansson L O. Contrast-enhanced coronary MRA.  J Magn Reson Imaging. 1999;  10 703-708
• 19 Paetsch I, Huber M E, Bornstedt A et al.. Improved three-dimensional free-breathing coronary magnetic resonance angiography using gadocoletic acid (B-22956) for intravascular contrast enhancement.  J Magn Reson Imaging. 2004;  20 288-293
• 20 Nikolaou K, Becker C R, Muders M et al.. Multidetector-row computed tomography and magnetic resonance imaging of atherosclerotic lesions in human ex vivo coronary arteries.  Atherosclerosis. 2004;  174 243-252
• 21 Nikolaou K, Becker C R, Flohr T et al.. Optimization of ex vivo CT- and MR- imaging of atherosclerotic vessel wall changes.  Int J Cardiovasc Imaging. 2004;  20 327-334
• 22 Itskovich V V, Samber D D, Mani V et al.. Quantification of human atherosclerotic plaques using spatially enhanced cluster analysis of multicontrast-weighted magnetic resonance images.  Magn Reson Med. 2004;  52 515-523
• 23 Botnar R M, Kim W Y, Bornert P, Stuber M, Spuentrup E, Manning W J. 3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisition.  Magn Reson Med. 2001;  46 848-854
• 24 Botnar R M, Stuber M, Kissinger K V, Kim W Y, Spuentrup E, Manning W J. Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging.  Circulation. 2000;  102 2582-2587
• 25 Fayad Z A, Fuster V, Fallon J T et al.. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging.  Circulation. 2000;  102 506-510
• 26 Kim W Y, Stuber M, Bornert P, Kissinger K V, Manning W J, Botnar R M. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease.  Circulation. 2002;  106 296-299
• 27 Glagov S, Weisenberg E, Zarins C K, Stankunavicius R, Kolettis G J. Compensatory enlargement of human atherosclerotic coronary arteries.  N Engl J Med. 1987;  316 1371-1375
• 28 Gawaz M, Konrad I, Hauser A I et al.. Non-invasive imaging of glycoprotein VI binding to injured arterial lesions.  Thromb Haemost. 2005;  93 910-913
• 29 Ginsberg H N, Goldsmith S J, Vallabhajosula S. Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patients.  Arteriosclerosis. 1990;  10 256-262
• 30 Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss H W. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study.  Circulation. 2001;  104 203-208
• 31 Mettinger K L, Larsson S, Ericson K, Casseborn S. Detection of atherosclerotic plaques in carotid arteries by the use of 123I-fibrinogen.  Lancet. 1978;  1 242-244
• 32 Schafers M, Riemann B, Kopka K et al.. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo.  Circulation. 2004;  109 2554-2559
• 33 Davis H H, Heaton W A, Siegel B A et al.. Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets.  Lancet. 1978;  1 1185-1187
• 34 Heyn C, Ronald J A, Mackenzie L T et al.. In vivo magnetic resonance imaging of single cells in mouse brain with optical validation.  Magn Reson Med. 2006;  55 23-29
• 35 Dodd S J, Williams M, Suhan J P, Williams D S, Koretsky A P, Ho C. Detection of single mammalian cells by high-resolution magnetic resonance imaging.  Biophys J. 1999;  76 103-109
• 36 Hinds K A, Hill J M, Shapiro E M et al.. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells.  Blood. 2003;  102 867-872
• 37 Morawski A M, Winter P M, Crowder K C et al.. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI.  Magn Reson Med. 2004;  51 480-486
• 38 Winter P M, Morawski A M, Caruthers S D et al.. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.  Circulation. 2003;  108 2270-2274
• 39 Flacke S, Fischer S, Scott M J et al.. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques.  Circulation. 2001;  104 1280-1285
• 40 Frias J C, Williams K J, Fisher E A, Fayad Z A. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques.  J Am Chem Soc. 2004;  126 16316-16317
• 41 Sirol M, Fuster V, Badimon J J et al.. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent.  Circulation. 2005;  112 1594-1600
• 42 Kooi M E, Cappendijk V C, Cleutjens K B et al.. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging.  Circulation. 2003;  107 2453-2458
• 43 Corti R, Fuster V, Fayad Z A et al.. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging.  J Am Coll Cardiol. 2005;  46 106-112
• 44 Schmitz S A, Coupland S E, Gust R et al.. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits.  Invest Radiol. 2000;  35 460-471
• 45 Schmitz S A, Taupitz M, Wagner S et al.. Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques: postmortem analysis of accuracy, inter-observer agreement, and pitfalls.  Invest Radiol. 2002;  37 405-411
• 46 Botnar R M, Buecker A, Wiethoff A J et al.. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.  Circulation. 2004;  110 1463-1466
• 47 Spuentrup E, Buecker A, Katoh M et al.. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent.  Circulation. 2005;  111 1377-1382
• 48 Fayad Z A, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque.  Circ Res. 2001;  89 305-316